Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Metabolon is a technology company, develops analytical methods and software for biomarker discovery using metabolomics. It offers a biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. Metabolon provides a unique, real-time fingerprint of biological system to reveal novel discoveries and realize the promise of precision medicine. The company can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of the disease, medical intervention, diet, or the environment. This deep and comprehensive view of the metabolome provides biological insights that cannot be revealed through any other research methodology, enabling life sciences researchers and drug developers to discover answers to some of biology’s most difficult questions. Metabolon was founded in 2000 and headquartered in Durham, North Carolina.

Biocrates is a developer of a metabolomics platform designed to support the discovery and validation of biomarkers for complex diseases. The company's metabolomics platform comprises an automated sample preparation workflow integrated with sensitive mass-spectrometric methods and software that controls sample management, data collection, and analysis to identify hundreds of metabolites, enabling physicians to acquire comprehensive metabolic information quickly and reliably.

Yantai New Era Health Industry Co., Ltd., established on 1995-10-08, Business scope includes licensed projects:Health food production;food production;food sales;road freight transport(Does not contain dangerous goods);Urban distribution transportation service(Does not contain dangerous goods);Catering Services;accommodation service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Biochemical product technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;food sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Wholesale of kitchenware, sanitary ware and daily sundries;Home Appliance Sales;internet sales(Except for products that require a license for sale);Manufacture of Home Textiles;electronics sales;General merchandise sales;Food import and export;Daily necessities wholesale;Import and export;Technology Import and Export;Conference and Exhibition Services;Arts and crafts and collectibles retail(Except for ivory and its products);Arts and crafts and collectibles wholesale(Except for ivory and its products);General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval);Operation of Road Freight Transport Station;Supply Chain Management Services;Storage equipment rental service;Loading and unloading;Leisure and sightseeing activities;Scenic spot management.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

London Health Sciences Centre Research, Inc. (doing business as Lowson Health Research Institute) is a private company headquartered in Canada. The firm operates as a hospital.

Valio Oy produces dairy products. Its products include milk, cream, yogurt, cheese, butter, quark, sour milk, and curd. The firm also offers milk powders, baby foods, infant formulas, puddings, and dessert sauces. The company was founded on September 13, 1905 and is headquartered in Helsinki, Finland.

Beijing Boyuan Precision Medical Technology Co., Ltd., established on 2016-10-10, Business scope includes technical promotion services;Medical Research(Does not include medical services);health management(Except for medical treatment activities subject to approval);Health Advisory(Except for medical treatment activities subject to approval);hospital management;Import and export;SalesIclass of medical devices,Instrumentation,electronic product;software development;design,make,acting,Place an ad;Conference Services;Undertake exhibition and display activities;Computer System Services;Economic and Trade Consulting.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.

Univera Co. Ltd. is a South Korean private company located in Seoul that develops and markets nutritional health products. Byung-Hoon Lee is currently the CEO of the firm.

KBSI conducts research support and joint research using advanced research facilities and equipment.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

CyteGen discovers new pathways that impact mitochondrial fitness and demonstrated recovery of cardiovascular and neurological function via therapeutic intervention.

Chongqing Weipu Pharmaceutical Technology Co., Ltd., established on 2020-07-31, Business scope includes licensed projects:Internet information service,Various construction activities,career brokerage,HR Services(Excludes job brokerage activities,Labor dispatch service)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development,Natural science research and experimental development,Information Technology Consulting Services,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,business management,software development,Health Consulting Services(Does not include medical services),Sales of Class I Medical Devices,Sales of Class II Medical Devices,Cosmetics Retail,Research and development of biopesticide technology,Research and development of bio-based material polymerization technology,Bio-organic fertilizer research and development,Research and development of compound microbial fertilizer,Bio-feed R&D,Research and development of bio-based materials technology,Biochemical product technology research and development,Sales of renewable resources,Eco-environmental material sales,Sales of ecological environment monitoring and testing instruments,Sales of water pollutant monitoring and testing instruments,Specialty Chemicals Sales(Free of Hazardous Chemicals),Research and development of special electronic materials,Resource recycling technology research and development,Retailing of computer software, hardware and auxiliary equipment,Engineering and Technology Research and Experimental Development,Technology intermediary service,Information Consulting Service(Not including licensing information consulting services),Conference and Exhibition Services,Technology guidance,Educational Consulting Services(Education and training activities that do not include licensing approval),Sales of new energy vehicle battery replacement facilities,Information system integration service,Software outsourcing service,Organize cultural and artistic exchange activities(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Guangdong Xinghai Biological Technology Co., Ltd., established on 2021-11-01, Business scope includes licensed projects:medical service;Production of hygiene products and single-use medical products;Cosmetic production;Health food production;Production of formula food for special medical purpose;food production;Food additive production;Import and export of edible fungi;Food Internet Sales;food sales;Disinfectant production(Free of Hazardous Chemicals);Production of disinfection products for the prevention and control of infectious diseases;Production of sterile equipment;Inspection and testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:R&D and application of cell technology;Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology intermediary service;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Conference and Exhibition Services;Information Consulting Service(Not including licensing information consulting services);Health Consulting Services(Does not include medical services);internet sales(Except for products that require a license for sale);Food Additive Sales;Cosmetics Retail.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shenzhen Human Metabolomics Institute, Inc., referred to as "Huayun Bio", was founded by an internationally renowned metabolomics research team returning to China. It is a company dedicated to developing and providing chronic disease diagnosis and early warning. National high-tech enterprises for innovative technologies and solutions and interventions. At present, Huiyun Bio has a series of in vitro diagnostic kits, intelligent auxiliary software, and health drinks with independent intellectual property rights, and provides a number of scientific research and medical inspection services.

Matrepu Biotechnology (Shanghai) Co., Ltd., established on 2016-03-31, Business scope includes general items:Engaged in technical services in the field of biotechnology,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,laboratory reagent(In addition to dangerous goods),Equipment,Computer hardware and software and accessories,Sales of instrumentation,Conference and Exhibition Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)